{
  "created_at": "Wed Sep 29 6:41:50 +0000 2021",
  "id_str": "1443067861472251906",
  "full_text": "India is the first country to approve a new type of jab to fight covid-19 https://t.co/5k2KH7ZKBj",
  "display_text_range": [
    0,
    97
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/5k2KH7ZKBj",
        "expanded_url": "https://econ.st/3kMhgJA",
        "display_url": "econ.st/3kMhgJA",
        "indices": [
          74,
          97
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 35,
  "favorite_count": 85,
  "possibly_sensitive": false,
  "original_created_at": "Wed Sep 29 04:19:23 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "インドがコヴィド-19と戦うための新しいタイプのジャブを承認した最初の国となる https://t.co/5k2KH7ZKBj"
    },
    {
      "locale": "zh",
      "full_text": "印度是第一个批准使用新型针剂来对抗covid-19的国家 https://t.co/5k2KH7ZKBj"
    },
    {
      "locale": "zh-Hant",
      "full_text": "印度是第一個批准使用新型針劑來對抗covid-19的國家 https://t.co/5k2KH7ZKBj"
    }
  ]
}